No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

byKathleen Lau

May 27, 2022

in StudyGraphics

Reading Time: 1 min read

Medical cannabis provides little improvement to sleep in chronic pain patients

RelatedReports

Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors

Cardiology

Exercise improves outcomes in patients with cardiovascular disease

February 8, 2023

Chronic Disease

Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults

January 24, 2023

StudyGraphics

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

November 17, 2022

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Chronic Disease

Roflumilast cream superior to vehicle cream in the treatment of plaque psoriasis – the DERMIS-1 and DERMIS-2 trials

September 24, 2022

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

2 Minute Medicine Rewind May 30, 2022

Shift workers may have increased sleep disruption and use of sleep medication

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

Exercise improves outcomes in patients with cardiovascular disease

Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

Exercise improves outcomes in patients with cardiovascular disease

Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

Roflumilast cream superior to vehicle cream in the treatment of plaque psoriasis – the DERMIS-1 and DERMIS-2 trials

2 Minute Medicine Rewind May 30, 2022

Shift workers may have increased sleep disruption and use of sleep medication

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

RELATED REPORTS

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?